Share Article

UsToo and Dr. Daniel Fried Present Live Webcast and Q and A on Prostate Cancer Radiation Therapy

Request More Information
Summary of Article

The event featured a presentation from renowned radiation oncologist Daniel B. Fried, MD, MPH, PhD, who practices at the Gibbs Cancer Center and Research Institute in Greenville, S.C discussing radiation therapy as an option for prostate cancer treatment.

In the fall of 2017, Us TOO International held a live webcast on radiation therapy for their prostate cancer support group meeting. The event, held in Greenville, SC, was sponsored by Augmenix, INC. The topic for the meeting was “Hydrogel Rectal Spacer in Prostate Radiotherapy”, specifically highlighting SpaceOAR hydrogel.

Dr. Daniel Fried, a radiation oncologist from Gibbs Cancer Center and Research Institute, was the speaker at the meeting, presenting on his experience with SpaceOAR hydrogel as well as answering questions from the audience about prostate cancer treatment and diagnosis. Gibbs Cancer Center and Research Institute is the first SpaceOAR National Education Resource Center.

Dr. Daniel Fried discusses radiation therapy for Prostate Cancer at an UsToo Support group meeting held in Greenville, SC
Dr. Fried addresses questions from the audience
The audience had some great questions for Dr. Fried.
Johnny Payne, Leader of the Us TOO support group in Greenville, SC

More than 160,000 men will be diagnosed with prostate cancer in 2017 and we’re on a mission to help educate those affected so they’re empowered to make informed decisions on all aspects of the disease,”

-Chuck Strand, CEO, Us TOO International.

Us TOO’s mission is to provide hope and improvement to the lives of the prostate cancer patients as well as their families and friends through support, education, and advocacy/awareness. Representatives of Us TOO whom attended the webinar included CEO Chuck Strand, Terri Likowski, Program Director/Support Group Services, and Johnny Payne, the Leader of the Us TOO Harvey Floyd Support Group.

“If detected early, prostate cancer is often treatable and knowledge of treatment options can lead to optimal outcomes. We are privileged to partner with Us TOO on patient-centric activities that aim to educate, empower and support these men and their families.”

-John Pedersen, CEO, Augmenix.

Watch Now

To find a local Us TOO International support group, visit http://www.ustoo.org/Support-Group-Near-You.

For more information on SpaceOAR hydrogel click here.